Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

REGN Regeneron Pharmaceuticals

688.530
-16.890-2.39%
Trading Session 09/29 10:08 ET
High
706.585
Open
704.830
Turnover
83.43M
Low
686.960
Pre Close
705.420
Volume
119.71K
Market Cap
75.06B
P/E(TTM)
13.78
52wk High
754.670
Shares
109.01M
P/E(Static)
9.57
52wk Low
538.010
Float Cap
71.32B
Bid/Ask %
-33.33%
Historical High
754.670
Shs Float
103.58M
Volume Ratio
1.61
Historical Low
4.610
Dividend TTM
--
Div Yield TTM
--
P/B
3.63
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.12%
Amplitude
2.78%
Avg Price
696.913
Lot Size
1
Float Cap
71.32B
Bid/Ask %
-33.33%
Historical High
754.670
Shs Float
103.58M
Volume Ratio
1.61
Historical Low
4.610
Dividend TTM
--
P/B
3.63
Dividend LFY
--
Turnover Ratio
0.12%
Amplitude
2.78%
Avg Price
696.913
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
CEO: Dr. Leonard S. Schleifer,M.D.,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...